{"schema_version":"secwatch.filing_event.v1","accession":"0001680367-21-000035","form_type":"8-K","ticker":"STTK","cik":"0001680367","company_name":"Shattuck Labs, Inc.","filed_at":"2021-08-11T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.140389+00:00","generated_at":"2026-06-29T15:15:40.001838+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Shattuck Labs reports Q2 net loss of $23.6M; pipeline advances with SL-172154 and SL-279252","bullets":["Net loss $23.6M ($0.56 loss per share) vs $6.2M ($0.81 loss per share) in Q2 2020; revenue negative $4.2M due to Takeda collaboration cost changes.","Cash and investments $304.8M as of June 30, 2021; cash runway expected through 2024, beyond Phase 1 results.","SL-172154 Phase 1 in ovarian cancer: dose escalation at 3.0 mg/kg, plans to advance to 10.0 mg/kg; no dose-limiting toxicities observed.","SL-279252 Phase 1: additional dose cohorts at 12.0 and 24.0 mg/kg based on pharmacodynamic data; SITC abstracts submitted for November 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001680367-21-000035","json":"https://secwatch.observer/filing/0001680367-21-000035.json","markdown":"https://secwatch.observer/filing/0001680367-21-000035.md","text":"https://secwatch.observer/filing/0001680367-21-000035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1680367/000168036721000035/0001680367-21-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1680367/000168036721000035/sttk-20210811.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T15:15:40.001838+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}